Loading the state's markets…
Loading the state's markets…
Medicare volume, surgeons and outlook for 50 device-driven procedures, CMS 2024
Share of surgeons' claims in surgery centers and offices.
Today's surgeons with a 50%+ chance of no longer billing it here.
Share of the named cases done by the 10 busiest surgeons.
MedaRep names every surgeon in each market, ranked by volume, with their practice, hospitals, trend, forecast and which device companies already engage with them.
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Decompression & minimally invasive spine | 67 | 2,826−4.4%/yr | −4.4%/yr | 2.91.1× | 0% | 3,400 in 2030+3.1%/yr |
| Lumbar fusion | 61 | 2,186+0.3%/yr | +0.3%/yr | 2.31.1× | 0% | 2,550 in 2030+2.6%/yr |
| Cervical fusion & disc arthroplasty | 23 | 1,163−2.2%/yr | −2.2%/yr | 1.21.2× | 0% | 1,360 in 2030+2.6%/yr |
| Kyphoplasty & vertebroplasty | 16 | 1,156−2.5%/yr | −2.5%/yr | 1.21.6× | 7% | 1,260 in 2030+1.5%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Debridement & negative-pressure wound therapy | 322 | 84,716+0.7%/yr | +0.7%/yr | 86.61.0× | 27% | 100,100 in 2030+2.8%/yr |
| Skin substitutes & wound grafts | 33 | 6,154+1.6%/yr | +1.6%/yr | 4.70.9× | 36% | 6,700 in 2030+1.4%/yr |
| Bone graft & orthobiologics | 14 | 581−11%/yr | −11%/yr | 0.61.3× | 0% | 650 in 2030+1.9%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Radiofrequency ablation (facet, genicular, basivertebral) | 107 | 7,050+1.9%/yr | +1.9%/yr | 7.21.0× | 43% | 9,910 in 2030+5.8%/yr |
| Peripheral nerve stimulation & intrathecal pumps | 17 | 831+11%/yr | +11%/yr | 0.81.2× | 6% | 820 in 2030−0.3%/yr |
| Spinal cord & DRG stimulation | 5 | 264−7.2%/yr | −7.2%/yr | 0.30.7× | 15% | 380 in 2030+6.4%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Peripheral arterial intervention | 34 | 3,386−4.6%/yr | −4.6%/yr | 3.50.7× | 43% | 4,060 in 2030+3.1%/yr |
| Dialysis access | 31 | 2,905−7.2%/yr | −7.2%/yr | 3.20.5× | 22% | 3,070 in 2030+0.9%/yr |
| Superficial venous ablation | 31 | 1,623−5%/yr | −5%/yr | 1.70.5× | 94% | 1,600 in 2030−0.3%/yr |
| Carotid revascularization | 18 | 984−3.3%/yr | −3.3%/yr | 1.01.0× | 0% | 1,170 in 2030+2.9%/yr |
| Thrombectomy, IVC filters & venous stents | 2 | 738−0.4%/yr | −0.4%/yr | 0.80.6× | 9% | 740 in 2030+0.1%/yr |
| Aortic endografts (EVAR/TEVAR) | 1 | 350−5.5%/yr | −5.5%/yr | 0.40.8× | 0% | 390 in 2030+1.8%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Hernia repair | 66 | 5,037−2.7%/yr | −2.7%/yr | 5.60.9× | 1% | 5,860 in 2030+2.6%/yr |
| Cholecystectomy & appendectomy | 60 | 3,162−3.7%/yr | −3.7%/yr | 3.40.9× | 0% | 3,520 in 2030+1.8%/yr |
| Colorectal resection | 10 | 1,485−3.1%/yr | −3.1%/yr | 1.61.0× | 0% | 1,660 in 2030+1.9%/yr |
| Antireflux & hiatal hernia surgery | 8 | 640+1.2%/yr | +1.2%/yr | 0.71.1× | 0% | 1,240 in 2030+12%/yr |
| Breast reconstruction | 1 | 327−2.7%/yr | −2.7%/yr | 0.30.8× | 0% | 340 in 2030+0.7%/yr |
| Bariatric surgery | 0 | 230−14%/yr | −14%/yr | 0.21.4× | 0% | 190 in 2030−2.8%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Kidney stone management | 93 | 4,315−1.9%/yr | −1.9%/yr | 4.60.8× | 8% | 4,690 in 2030+1.4%/yr |
| Hysterectomy, hysteroscopy & ablation | 41 | 3,182−0.5%/yr | −0.5%/yr | 3.61.1× | 17% | 3,720 in 2030+2.6%/yr |
| BPH procedures | 46 | 2,725−3.2%/yr | −3.2%/yr | 2.90.6× | 13% | 2,910 in 2030+1.1%/yr |
| Incontinence, prolapse & sacral neuromodulation | 30 | 1,885+3.7%/yr | +3.7%/yr | 2.01.1× | 1% | 2,140 in 2030+2.1%/yr |
| Prostatectomy & nephrectomy | 10 | 885−2.7%/yr | −2.7%/yr | 1.00.8× | 0% | 1,070 in 2030+3.2%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Sinus surgery & balloon dilation | 25 | 2,622−3.9%/yr | −3.9%/yr | 2.80.8× | 53% | 3,080 in 2030+2.7%/yr |
| Ear tubes & middle ear surgery | 0 | 237−3.1%/yr | −3.1%/yr | 0.31.0× | 36% | 130 in 2030−10%/yr |
| Cochlear implants | 4 | 130+3.6%/yr | +3.6%/yr | 0.11.6× | 0% | 220 in 2030+9.5%/yr |
| Sleep apnea & airway implants | 2 | 127+63%/yr | +63%/yr | 0.11.2× | 0% | 110 in 2030−2.2%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Breast biopsy & localization | 117 | 7,183−0.3%/yr | −0.3%/yr | 8.00.9× | 12% | 8,190 in 2030+2.2%/yr |
| Tumor & fibroid embolization | 12 | 677+16%/yr | +16%/yr | 0.71.2× | 46% | 1,170 in 2030+9.5%/yr |
| Tumor ablation | 4 | 431−1.7%/yr | −1.7%/yr | 0.51.8× | 0% | 590 in 2030+5.3%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| CGM & insulin pump management | 240 | 25,322+25%/yr | +25%/yr | 26.40.9× | 64% | 50,400 in 2030+12%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Pacemaker, ICD & CRT implantation | 90 | 4,351−1.6%/yr | −1.6%/yr | 4.71.0× | 0% | 4,910 in 2030+2%/yr |
| EP ablation | 73 | 4,222+12%/yr | +12%/yr | 4.01.2× | 0% | 9,560 in 2030+15%/yr |
| LAA occlusion & loop recorders | 67 | 2,548+8.4%/yr | +8.4%/yr | 2.40.7× | 8% | 4,890 in 2030+11%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Coronary intervention (PCI) | 103 | 4,352−4.8%/yr | −4.8%/yr | 4.00.8× | 0% | 4,790 in 2030+1.6%/yr |
| Structural heart (TAVR, TEER) | 66 | 2,037+3.4%/yr | +3.4%/yr | 1.91.1× | 0% | 3,210 in 2030+7.9%/yr |
| Mechanical circulatory support | 3 | 596−1.7%/yr | −1.7%/yr | 0.61.1× | 0% | 560 in 2030−0.9%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Aneurysm & intracranial embolization | 13 | 456+8%/yr | +8%/yr | 0.50.9× | 0% | 820 in 2030+10%/yr |
| Stroke thrombectomy | 15 | 351+2.1%/yr | +2.1%/yr | 0.40.8× | 0% | 410 in 2030+2.8%/yr |
| DBS & VNS | 6 | 233−7.5%/yr | −7.5%/yr | 0.20.9× | 0% | 270 in 2030+2.6%/yr |
| CSF shunts | 5 | 193−8.4%/yr | −8.4%/yr | 0.21.0× | 0% | 220 in 2030+1.9%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Cataract & MIGS | 256 | 48,337+1.2%/yr | +1.2%/yr | 50.41.0× | 83% | 55,500 in 2030+2.3%/yr |
| Vitreoretinal surgery | 29 | 1,871−4.2%/yr | −4.2%/yr | 2.01.0× | 38% | 2,190 in 2030+2.6%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Colonoscopy & upper endoscopy | 512 | 113,822−0.9%/yr | −0.9%/yr | 123.61.0× | 22% | 128,100 in 2030+2%/yr |
| ERCP & endoscopic ultrasound | 60 | 4,610+2.9%/yr | +2.9%/yr | 4.91.4× | 0% | 6,530 in 2030+6%/yr |
| Bronchoscopy & lung nodule | 48 | 3,057+5.5%/yr | +5.5%/yr | 3.31.1× | 0% | 4,980 in 2030+8.5%/yr |
How the numbers are made · Every state · Compare two markets
Share of the orthopedic, spine, extremity and wound cases CMS names by surgeon, by where the surgeon billed. Open a metro for its ranking.